Keyphrases
Cancer-related
100%
Cushing's Syndrome
100%
Adolescent Patients
100%
Vandetanib
100%
Medullary Thyroid Cancer
100%
Tyrosine Kinase Inhibitor
60%
Ectopic Cushing's Syndrome
60%
Clinical Symptoms
20%
Pediatric Patients
20%
ACTH Secretion
20%
Neuroendocrine Tumor
20%
Serum Cortisol
20%
ACTH-dependent
20%
Pediatric Case
20%
Multiple Endocrine Neoplasia Type 2 (MEN2)
20%
Paraneoplastic
20%
Medicine and Dentistry
Thyroid Cancer
100%
Vandetanib
100%
Cushing Syndrome
100%
Tyrosine-Kinase Inhibitor
42%
Corticotropin
28%
Secretion (Process)
14%
Pediatrics
14%
Hydrocortisone
14%
Pediatrics Patient
14%
Neuroendocrine Tumor
14%
Multiple Endocrine Neoplasia Type 2b
14%
Clinical Symptom
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cushing Syndrome
100%
Thyroid Cancer
100%
Vandetanib
100%
Protein Tyrosine Kinase Inhibitor
42%
Corticotropin
28%
Hydrocortisone
14%
Neuroendocrine Tumor
14%
Multiple Endocrine Neoplasia Type 2b
14%